期刊文献+

美国乳腺与肠道外科辅助治疗研究组结直肠癌临床试验研究进展 被引量:1

Advances on National Surgical Adjuvant Breast and Bowel Project colorectal cancer trials
原文传递
导出
摘要 美国乳腺与肠道外科辅助治疗研究组由美国国家癌症研究中心资助,主要进行大规模乳腺癌和结直肠癌临床试验。其临床试验为乳腺癌以及结直肠癌的治疗提供了重要的参考和指导价值。近5年来,NSABP结直肠癌临床试验就新的辅助化疗方案、靶向药物的作用以及直肠癌的新辅助治疗和辅助治疗的作用进行了深入的研究,取得了一些新的进展。 The National Surgical Adjuvant Breast and Bowel Project (NSABP) is a clinical trials cooperative group supported by the National Cancer Institute (NCI). The NSABP has conducted clinical trials in breast and colorectal cancer for nearly 40 years, many of which have greatly improved the therapies in breast and colorectal cancers. There have been some new advances on new adjuvant chemotherapy regimens, targeted therapy, adjuanvt and neoadjuvant therapies for rectal cancer in recent 5 years.
出处 《国际肿瘤学杂志》 CAS 2011年第12期930-933,共4页 Journal of International Oncology
关键词 结直肠肿瘤 临床试验 Colorectal neoplasms Clinical trial
  • 相关文献

参考文献13

  • 1Wilkinson NW, Yothers G, Lopa S, et al. Long-term survival results of surgery alone ,Jersus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol, 2010, 17(4) :959-966.
  • 2Lembersky BC, Wieand HS, Petrelli NJ, et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon : results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol, 2006, 24(13) :2059-2064.
  • 3Kopec JA, Yothers G, Ganz PA, et al. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. J Clin Oncol, 2007, 25(4) :424-430.
  • 4Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol, 2009, 27 (19) :3109-3116.
  • 5Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol, 2007, 25 (16) :2198-2204.
  • 6Land SR, Kopec JA, Cecchini RS, et al. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol, 2007, 25(16) :2205-2211.
  • 7Kuebler JP, Colangelo L, O'Connell MJ, et al. Severe enteropathy among patients with stage II/ III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis. Cancer, 2007, 110(9) :1945-1950.
  • 8Sharif S, O'Connell MJ, Yothers G, et al. FOLFOX and FLOX regi- mens for the adjuvant treatment of resected stage II and III colon cancer. Cancer Invest, 2008, 26(9) :956-963.
  • 9Allegxa CJ, Yothers G, O'Connell MJ, et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol, 2011,29(1) :11-16.
  • 10Alberts SR, Roh MS, Mahoney MR, et al. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colo- rectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66. J Clin Oncol, 2010, 28 (5) :853-858.

同被引文献10

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部